These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 9103129)
21. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study. Bianconi L; Mennuni M; Lukic V; Castro A; Chieffi M; Santini M J Am Coll Cardiol; 1996 Sep; 28(3):700-6. PubMed ID: 8772759 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study. Kosior DA; Kochanowski J; Scisło P; Piatkowski R; Postuła M; Rabczenko D; Opolski G Cardiol J; 2009; 16(6):521-7. PubMed ID: 19950088 [TBL] [Abstract][Full Text] [Related]
24. Pharmacological conversion of recent atrial fibrillation: a randomized, placebo-controlled study of three antiarrhythmic drugs. Balla I; Petrela E; Kondili A Anadolu Kardiyol Derg; 2011 Nov; 11(7):600-6. PubMed ID: 21911317 [TBL] [Abstract][Full Text] [Related]
25. Intravenous propafenone versus intravenous amiodarone in the management of atrial fibrillation of recent onset: a placebo-controlled study. Kochiadakis GE; Igoumenidis NE; Simantirakis EN; Marketou ME; Parthenakis FI; Mezilis NE; Vardas PE Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2475-9. PubMed ID: 9825370 [TBL] [Abstract][Full Text] [Related]
26. [A comparison between propafenone and hydroquinidine perorally in the treatment of recent-onset atrial fibrillation]. Satullo G; Arrigo F; Cavallaro L; Coglitore A; Fazio F; Saporito F; Sorrenti S; Oreto G Minerva Cardioangiol; 1996 Mar; 44(3):141-4. PubMed ID: 8767614 [TBL] [Abstract][Full Text] [Related]
27. Propafenone for the treatment of supraventricular tachycardia and atrial fibrillation: a meta-analysis. Reimold SC; Maisel WH; Antman EM Am J Cardiol; 1998 Oct; 82(8A):66N-71N. PubMed ID: 9809903 [TBL] [Abstract][Full Text] [Related]
28. A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm. Capucci A; Boriani G; Rubino I; Della Casa S; Sanguinetti M; Magnani B Int J Cardiol; 1994 Mar; 43(3):305-13. PubMed ID: 8181888 [TBL] [Abstract][Full Text] [Related]
29. Predictors of success in the conversion of new-onset atrial fibrillation using oral propafenone. Ergene U; Ergene O; Cete Y; Fowler J; Nazli C; Oktay C Eur J Emerg Med; 1998 Dec; 5(4):425-8. PubMed ID: 9919447 [TBL] [Abstract][Full Text] [Related]
30. Placebo-controlled evaluations of propafenone for atrial tachyarrhythmias. Rae AP Am J Cardiol; 1998 Oct; 82(8A):59N-65N. PubMed ID: 9809902 [TBL] [Abstract][Full Text] [Related]
31. Randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a single oral dose of vanoxerine for the conversion of subjects with recent onset atrial fibrillation or flutter to normal sinus rhythm: RESTORE SR. Piccini JP; Pritchett EL; Davison BA; Cotter G; Wiener LE; Koch G; Feld G; Waldo A; van Gelder IC; Camm AJ; Kowey PR; Iwashita J; Dittrich HC Heart Rhythm; 2016 Sep; 13(9):1777-83. PubMed ID: 27108936 [TBL] [Abstract][Full Text] [Related]
32. Propafenone versus vernakalant for conversion of recent-onset atrial fibrillation. Conde D; Costabel JP; Aragon M; Lambardi F; Klein A; Corrales Barbosa A; Trivi M; Giniger A Cardiovasc Ther; 2013 Dec; 31(6):377-80. PubMed ID: 23683253 [TBL] [Abstract][Full Text] [Related]
33. Propafenone in the conversion of atrial fibrillation in patients suffering from chronic renal failure. Napoli C; Sorice P; Di Benedetto A; Di Ieso N; Liguori A Am J Ther; 1997 Apr; 4(4):130-3. PubMed ID: 10423602 [TBL] [Abstract][Full Text] [Related]
34. Intravenous propafenone for converting recent onset atrial fibrillation in emergency departments: a randomized placebo-controlled multicenter trial. FAPS Investigators Study Group. Ganau G; Lenzi T J Emerg Med; 1998; 16(3):383-7. PubMed ID: 9610964 [TBL] [Abstract][Full Text] [Related]
35. [Pharmacological cardioversion of atrial fibrillation with intravenous and oral propafenone]. Peciuliene I; Lukoseviciūte A Medicina (Kaunas); 2002; 38(12):1212-6. PubMed ID: 12552163 [TBL] [Abstract][Full Text] [Related]
36. Management of patients with acute atrial fibrillation in the ED. Conti A; Del Taglia B; Mariannini Y; Pepe G; Vanni S; Grifoni S; Abbate R; Michelucci A; Padeletti L; Gensini GF Am J Emerg Med; 2010 Oct; 28(8):903-10. PubMed ID: 20825922 [TBL] [Abstract][Full Text] [Related]
37. [Comparison of efficacy, safety and cost-effectiveness of intravenous versus oral propafenone in paroxysmal atrial fibrillation]. Zadura M; Grossmann G; Modrzewska A; Klecha T; Klepacka H; Rumiński W Pol Merkur Lekarski; 2001 Aug; 11(62):137-9. PubMed ID: 11757212 [TBL] [Abstract][Full Text] [Related]
38. Oral loading with propafenone for conversion of recent-onset atrial fibrillation: a review on in-hospital treatment. Boriani G; Martignani C; Biffi M; Capucci A; Branzi A Drugs; 2002; 62(3):415-23. PubMed ID: 11827557 [TBL] [Abstract][Full Text] [Related]
39. Amiodarone versus propafenone for conversion of chronic atrial fibrillation: results of a randomized, controlled study. Kochiadakis GE; Igoumenidis NE; Parthenakis FI; Chlouverakis GI; Vardas PE J Am Coll Cardiol; 1999 Mar; 33(4):966-71. PubMed ID: 10091823 [TBL] [Abstract][Full Text] [Related]
40. Efficacy and speed of conversion of recent onset atrial fibrillation using oral propafenone versus parenteral amiodarone: A randomized controlled comparative study. Taha HS; Youssef G; Omar RM; Kamal El Din AM; Shams El Din AA; Meshaal MS Indian Heart J; 2022; 74(3):212-217. PubMed ID: 35452688 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]